Related references
Note: Only part of the references are listed.Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity
William W. Du et al.
CELL DEATH AND DIFFERENTIATION (2017)
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer
Jie Chen et al.
CANCER LETTERS (2017)
Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma
Meilin Qin et al.
CANCER BIOMARKERS (2016)
Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals
Liang Shi et al.
CANCER LETTERS (2016)
Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression
Liang Shi et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2
William W. Du et al.
NUCLEIC ACIDS RESEARCH (2016)
Circular RNAs in Brain and Other Tissues: A Functional Enigma
Wei Chen et al.
TRENDS IN NEUROSCIENCES (2016)
Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs
Qiupeng Zheng et al.
NATURE COMMUNICATIONS (2016)
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes
Yongchao Dou et al.
SCIENTIFIC REPORTS (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The RNA Binding Protein Quaking Regulates Formation of circRNAs
Simon J. Conn et al.
CELL (2015)
MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma
Songming Ding et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity
Xintian You et al.
NATURE NEUROSCIENCE (2015)
RNA rewriting, recoding, and rewiring in human disease
Maria Anna Zipeto et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Analysis of Intron Sequences Reveals Hallmarks of Circular RNA Biogenesis in Animals
Andranik Ivanov et al.
CELL REPORTS (2015)
Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer
Zhong Chen et al.
EMBO JOURNAL (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Correlation of circular RNA abundance with proliferation - exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues
Anna Bachmayr-Heyda et al.
SCIENTIFIC REPORTS (2015)
RNA Editome Imbalance in Hepatocellular Carcinoma
Lihua Qi et al.
CANCER RESEARCH (2014)
Complementary Sequence-Mediated Exon Circularization
Xiao-Ou Zhang et al.
CELL (2014)
Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis
Wen-Lung Ma et al.
ENDOCRINE-RELATED CANCER (2014)
Short intronic repeat sequences facilitate circular RNA production
Dongming Liang et al.
GENES & DEVELOPMENT (2014)
A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma
Tim Hon Man Chan et al.
GUT (2014)
Expanded identification and characterization of mammalian circular RNAs
Junjie U. Guo et al.
GENOME BIOLOGY (2014)
Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b
Jeong Kyu Kim et al.
HEPATOLOGY (2013)
Natural RNA circles function as efficient microRNA sponges
Thomas B. Hansen et al.
NATURE (2013)
Circular RNAs are a large class of animal RNAs with regulatory potency
Sebastian Memczak et al.
NATURE (2013)
Circular RNAs are abundant, conserved, and associated with ALU repeats
William R. Jeck et al.
RNA (2013)
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2012)
BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY
J. M. Llovet et al.
JOURNAL OF HEPATOLOGY (2012)
miR-195, miR-455-3p and miR-10a*are implicated in acquired temozolomide resistance in glioblastoma multiforme cells
Kenta Ujifuku et al.
CANCER LETTERS (2010)
Protective effect of 5-hydroxymethylfurfural derived from processed Fructus Corni on human hepatocyte LO2 injured by hydrogen peroxide and its mechanism
Xia Ding et al.
JOURNAL OF ETHNOPHARMACOLOGY (2010)
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
S. Whittaker et al.
ONCOGENE (2010)
Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma
Cheng-Lung Ma et al.
GASTROENTEROLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b
Gary K. Scott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing
CX George et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Androgen receptor (AR) coregulators: An overview
CA Heinlein et al.
ENDOCRINE REVIEWS (2002)
Share Paper
